| |
 |
|
Class Information
Number: 514/428
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) > The five-membered hetero ring consists of one nitrogen and four carbons > Chalcogen bonded indirectly to the five-membered hetero ring by acyclic nonionic bonding
Description:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 5889031 |
N-acyl-2-aryl cyclopropylmethylamine derivatives as melatonergics |
Mar. 30, 1999 |
| 5889000 |
Naphthofluorene compounds, intermediates, compositions and methods |
Mar. 30, 1999 |
| 5885985 |
Guanidine derivatives useful in therapy |
Mar. 23, 1999 |
| 5872117 |
1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same |
Feb. 16, 1999 |
| 5872134 |
5-HT4 receptor antagonists |
Feb. 16, 1999 |
| 5869067 |
Bi-aromatic compounds and pharmaceutical and cosmetic compositions |
Feb. 9, 1999 |
| 5863903 |
Use of hydroxy alkyl piperidine and pyrrolidine compounds to treat diabetes |
Jan. 26, 1999 |
| 5863912 |
Method of treatment of hormone-unresponsive metastiatic prostate cancer |
Jan. 26, 1999 |
| 5859045 |
Crystalline[-] 3R 4R-trans-7 methoxy 2,2-dimethyl1-3-phenyl 1-4 [4-12 [pyrrolidin-1 -Y1]ethoxyl 1]chromane hydrogen fumarate |
Jan. 12, 1999 |
| 5859048 |
Pharmaceutics for mucosal administration |
Jan. 12, 1999 |
| 5858402 |
Methods for in vivo reduction of cyanide levels and compositions useful therefor |
Jan. 12, 1999 |
| 5856331 |
Method for preventing tissue injury from hypoxia |
Jan. 5, 1999 |
| 5854277 |
Thiophenebutanoic acid derivatives as matrix metalloprotease inhibitors |
Dec. 29, 1998 |
| 5852047 |
Pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor |
Dec. 22, 1998 |
| 5849801 |
4-amino-5-oxy-2,6,6-trimethyl-2-cycloheptene compounds |
Dec. 15, 1998 |
| 5846980 |
N-(benzhydryloxyalkyl)-4-(carboxy/carbamoyl methyl)-piperidine derivatives as antidepressants |
Dec. 8, 1998 |
| 5843983 |
Diphenylethane compounds containing a saturated heterocyclic group, their preparation, and their therapeutic use |
Dec. 1, 1998 |
| 5837717 |
Hydroxamic acid anesthetic compounds |
Nov. 17, 1998 |
| 5837720 |
N-2-(pyrrolidinyl-1)-1-phenethyl) acetamides as kappa receptor antagonists |
Nov. 17, 1998 |
| 5830897 |
.alpha.- and .beta.-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
Nov. 3, 1998 |
| 5827876 |
Inhibition of bone loss by 3-(4-acrylamidobenzoyl) benzo[b]-thiophenes |
Oct. 27, 1998 |
| 5821253 |
Tetrahydrobenzo[a]fluorene compounds and methods of use |
Oct. 13, 1998 |
| 5821254 |
Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer |
Oct. 13, 1998 |
| 5821261 |
Substituted saturated aza heterocycles as inhibitors of nitric oxide synthase |
Oct. 13, 1998 |
| 5811421 |
Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods |
Sep. 22, 1998 |
| 5804595 |
Kappa opioid receptor agonists |
Sep. 8, 1998 |
| 5801197 |
Rotamase enzyme activity inhibitors |
Sep. 1, 1998 |
| 5792786 |
Non-steroidal anti-inflammatory fatty acid conjugates and their therapeutic use thereof |
Aug. 11, 1998 |
| 5792762 |
Dihydrobenzofluorene compounds, intermediates, compositions and methods |
Aug. 11, 1998 |
| 5780494 |
Piperidinyl-terminated alkylamino ethynl alanine amino diol compounds for treatment of hypertension |
Jul. 14, 1998 |
| 5780486 |
Heterocyclic compounds |
Jul. 14, 1998 |
| 5776972 |
Kappa-opiate agonists for inflammatory bowel disorders |
Jul. 7, 1998 |
| 5770609 |
Prevention and treatment of cardiovascular pathologies |
Jun. 23, 1998 |
| 5770624 |
Certain alpha-substituted arylsulfonamido acetohydroxamic acids |
Jun. 23, 1998 |
| 5767144 |
Endothelin antagonists |
Jun. 16, 1998 |
| 5763460 |
N-(piperidinyl-1-alkyl)-substituted cyclohexane carboxylic acid amides as 5-htia receptor antagonists |
Jun. 9, 1998 |
| 5756531 |
Iminoxy derivatives of indole and indene compounds as inhibitors of prostaglandin biosynthesis |
May. 26, 1998 |
| 5756533 |
Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
May. 26, 1998 |
| 5756426 |
Phenyl acetic acid derivatives as pesticides |
May. 26, 1998 |
| 5753715 |
2-disubstituted cyclohexenyl and cyclohexyl antimicrobial agents |
May. 19, 1998 |
| 5753680 |
Heterocyclyl-benzoylguanidines |
May. 19, 1998 |
| 5750559 |
Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs |
May. 12, 1998 |
| 5747523 |
Substituted ethyl .alpha.,.alpha.-diarylmethyl ether derivatives |
May. 5, 1998 |
| 5744468 |
Hypotensive intraocular pressure activity of clozapine and sulpiride |
Apr. 28, 1998 |
| 5741801 |
5-HT.sub.4 receptor antagonist |
Apr. 21, 1998 |
| 5739142 |
4-aminobenzoylguanidine derivatives |
Apr. 14, 1998 |
| 5739157 |
Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase |
Apr. 14, 1998 |
| 5736559 |
Biphenyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
Apr. 7, 1998 |
| 5731313 |
Use of anthracyclinone derivatives in amyloidosis |
Mar. 24, 1998 |
| 5731335 |
(1-Heteroazolyl-1-heterocycane derivatives and their use as neuroprotective agents |
Mar. 24, 1998 |
|
|
|
